After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a recent study. The research is published in Chronic ...
Additionally, a pMDI with a spacer is preferred to provide a sufficient dose in an emergency situation ... GSK, leading the COPD market with its Trelegy Ellipta inhaler, is planning pivotal ...
In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...